[1]
T. Sahin and E. Kocak, “The safety of alpha fetoprotein in diagnosis of hepatocellular carcinoma in patients with type 2 diabetes mellitus ”, Ann Med Res , vol. 26, no. 12, pp. 2961–2965, May 2021, Accessed: Sep. 17, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1883